Observational Trial of Cardiotoxicity in Patients Undergoing Chemotherapy.

2019-08-19 19:46:45 | BioPortfolio


Advances in treatment have led to improved survival of patients with cancer, but have also increased morbidity and mortality due to cancer treatment side effects. Cardiotoxicity is one the most frequent side effect which may lead to premature morbidity and death among cancer survivors. The most concerning cardiovascular complications of cancer therapy is myocardial dysfunction, leading to heart failure, and fatal arrhythmias, especially those induced by QT-prolonging drugs.

PROMETEY (PROspective Multidisciplinary obsErvational Trial of cardiotoxicity in patiEnts undergoing anticancer therapy) - is Russian multicenter observational study assessing cardiotoxicity and its clinical, biochemical and genetic factors in patients on cancer therapy.

The objectives of the study are:

- to reveal prevalence of cardiotoxic effects of cancer therapy in routine clinical practice in Russian Federation,

- to assess contribution of these effects to mortality of patients on cancer therapy,

- to evaluate clinical and economic consequences of cardiotoxicity in patients with cancer,

- to develop an individualized model of cardiotoxicity risk factors based on clinical and laboratory parameters.

Patients: 400 cancer patients with toxic cardiomyopathy and 100 patients with idiopathic or family dilated cardiomyopathy.

Study duration: 60 months. All patients will undergo complex examination after signing informed consent form(ICF): physical exam, echocardiography with speckle tracking analysis, ambulatory 48-hours ECG monitoring, biochemistry, analysis of biomarkers of myocardial injury, fibrosis and inflammation.

Primary endpoint: all-cause mortality, heart transplantation, cardioverter-defibrillator implantation, hospitalization with heart failure decompensation.

Secondary endpoints:

- thromboembolism,

- fatal/ nonfatal myocardial infarction, stroke,

- sudden cardiac death,

- surgical therapy of heart failure or arrhythmias,

- cardiovascular death,

- all-cause mortality,

- heart transplantation,

- cardioverter-defibrillator implantation.

Study Design




Echocardiography with speckle tracking analysis., 48-hour ECG monitoring., Blood samples analysis.


Moscow State University of Medicine and Dentistry, Department of Hospital Therapy №1
Moscow Region
Russian Federation




Moscow State University of Medicine and Dentistry

Results (where available)

View Results


Published on BioPortfolio: 2019-08-19T19:46:45-0400

Clinical Trials [2310 Associated Clinical Trials listed on BioPortfolio]

Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure

The overall objective of the study is to determine whether speckle tracking echocardiography presents additional prognostic value to the routine assessment (clinical and echocardiographic)...

Detection of Myocardial Dysfunction in Non-severe Subarachnoid Hemorrhage (WFNS 1-2) Using Speckle-tracking Echocardiography (STRAIN)

Subarachnoid hemorrhage (SAH) can cause transient myocardial dysfunction. Recently, it have been reported that myocardial dysfunctions that occur in SAH are associated with poor outcomes. ...

Speckle Tracking Echocardiography for the Prediction of Weaning Failure

Deciding the optimal timing for extubation in patients who are mechanically ventilated can be challenging, and traditional weaning predictor tools are not accurate. Recent studies suggest ...

Study on the Value of Three-dimensional Speckle Tracking Technique

For a long time, it has been hoped that doctors could screen and diagnosis of coronary heart disease through non-invasive imaging techniques, so as to maximize the benefit/risk ratio of pa...

Speckle-tracking Tricuspid Annular Plane Systolic Excursion

The study is designed to validate the use of speckle-tracking echocardiography to measure tricuspid annular plane systolic excursion as a measurement of right ventricular function during t...

PubMed Articles [23780 Associated PubMed Articles listed on BioPortfolio]

Assessment of right ventricular function and relation to mortality after acute pulmonary embolism: A speckle tracking echocardiography-based study.

Right ventricular (RV) dysfunction is a common condition that is related to increased adverse outcomes in patients with acute pulmonary embolism (APE). Our aim was to assess timing and magnitude of re...

Speckle Tracking Echocardiography and All-Cause and Cardiovascular Mortality Risk in Chronic Kidney Disease Patients.

Patients with chronic kidney disease (CKD) exhibit a highly increased risk of cardiovascular (CV) morbidity and mortality. Subtle changes in left ventricular function can be detected by two-dimensiona...

Evaluation of Left Atrial Functions by 2-dimensional Speckle-Tracking Echocardiography During Healthy Pregnancy.

We aimed to determine the effects of normal pregnancy on left atrial (LA) mechanics using 2-dimensional speckle-tracking echocardiography.

Exploring speckle-tracking echocardiography for the assessment of the diastolic functions: A step in the right direction.

More than 10 years of speckle tracking echocardiography: Still a novel technique or a definite tool for clinical practice?

Speckle tracking echocardiography (STE) cannot be considered a recent technique anymore. Its application has gained growing importance over the last decade in several clinical settings, and the deform...

Medical and Biotech [MESH] Definitions

Echocardiography amplified by the addition of depth to the conventional two-dimensional ECHOCARDIOGRAPHY visualizing only the length and width of the heart. Three-dimensional ultrasound imaging was first described in 1961 but its application to echocardiography did not take place until 1974. (Mayo Clin Proc 1993;68:221-40)

Method in which repeated blood pressure readings are made while the patient undergoes normal daily activities. It allows quantitative analysis of the high blood pressure load over time, can help distinguish between types of HYPERTENSION, and can assess the effectiveness of antihypertensive therapy.

The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine.

Dynamic three-dimensional echocardiography using the added dimension of time to impart the cinematic perception of motion. (Mayo Clin Proc 1993;68:221-40)

Echocardiography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image.

More From BioPortfolio on "Observational Trial of Cardiotoxicity in Patients Undergoing Chemotherapy."

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Searches Linking to this Trial